Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 732

1.

Development of varicella vaccine.

Takahashi M, Asano Y, Kamiya H, Baba K, Ozaki T, Otsuka T, Yamanishi K.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S41-4. doi: 10.1086/522132.

2.

The safety profile of varicella vaccine: a 10-year review.

Galea SA, Sweet A, Beninger P, Steinberg SP, Larussa PS, Gershon AA, Sharrar RG.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S165-9. doi: 10.1086/522125. Review.

3.

Attenuation and laboratory markers of the Oka-strain varicella-zoster virus.

Takahashi M, Hayakawa Y, Shiraki K, Yamanishi K, Asano Y, Ozaki T.

Postgrad Med J. 1985;61 Suppl 4:37-46.

PMID:
3014476
4.

Perspective on live varicella vaccine.

Gershon AA, Katz SL.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S242-5. doi: 10.1086/522151.

5.

Ten year follow-up of healthy children who received one or two injections of varicella vaccine.

Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, Reisinger K, Kim LL, Lupinacci L, Hartzel J, Chan I; Study Group for Varivax.

Pediatr Infect Dis J. 2004 Feb;23(2):132-7.

PMID:
14872179
6.

Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009.

Weinmann S, Chun C, Schmid DS, Roberts M, Vandermeer M, Riedlinger K, Bialek SR, Marin M.

J Infect Dis. 2013 Dec 1;208(11):1859-68. doi: 10.1093/infdis/jit405. Epub 2013 Aug 6.

7.

The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination.

Civen R, Chaves SS, Jumaan A, Wu H, Mascola L, Gargiullo P, Seward JF.

Pediatr Infect Dis J. 2009 Nov;28(11):954-9. doi: 10.1097/INF.0b013e3181a90b16.

PMID:
19536039
9.

The effect of vaccination on the epidemiology of varicella zoster virus.

Edmunds WJ, Brisson M.

J Infect. 2002 May;44(4):211-9. Review.

PMID:
12099726
10.

Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation.

Leung TF, Chik KW, Li CK, Lai H, Shing MM, Chan PK, Lee V, Yuen PM.

Bone Marrow Transplant. 2000 Jan;25(2):167-72.

11.

The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.

Reynolds MA, Chaves SS, Harpaz R, Lopez AS, Seward JF.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S224-7. doi: 10.1086/522162. Review.

12.

[A live attenuated varicella vaccine].

Asano Y.

Uirusu. 2009 Dec;59(2):249-55. Review. Japanese.

13.
14.

Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.

Leung TF, Li CK, Hung EC, Chan PK, Mo CW, Wong RP, Chik KW.

Eur J Haematol. 2004 May;72(5):353-7.

PMID:
15059071
15.

Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.

Breuer J, Whitley R.

Herpes. 2007 Sep;14 Suppl 2:25-9. Erratum in: Herpes. 2007 Dec;14(3):74.

PMID:
17939892
16.

[Modelling the impact of vaccination on the epidemiology of varicella zoster virus].

Bonmarin I, Santa-Olalla P, Lévy-Bruhl D.

Rev Epidemiol Sante Publique. 2008 Oct;56(5):323-31. doi: 10.1016/j.respe.2008.07.087. Epub 2008 Oct 31. French.

PMID:
18951741
17.

Pathogenesis and current approaches to control of varicella-zoster virus infections.

Gershon AA, Gershon MD.

Clin Microbiol Rev. 2013 Oct;26(4):728-43. doi: 10.1128/CMR.00052-13. Review.

18.

Consensus: varicella vaccination of healthy children--a challenge for Europe.

Rentier B, Gershon AA; European Working Group on Varicella.

Pediatr Infect Dis J. 2004 May;23(5):379-89. Review.

PMID:
15131459
19.

Universal varicella vaccination: efficacy trends and effect on herpes zoster.

Goldman GS.

Int J Toxicol. 2005 Jul-Aug;24(4):205-13.

PMID:
16126614
20.

Current status and prospects of live varicella vaccine.

Takahashi M.

Vaccine. 1992;10(14):1007-14. Review.

PMID:
1335196
Items per page

Supplemental Content

Write to the Help Desk